Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Indaptus Therapeutics, Inc.
The company signed a major contract or deal. An 8-K is the notice a US public company must file within four business days of a major event.
indaptusrx.comAI Executive Summary
AI-powered analysis of 8-K filing content
Indaptus Therapeutics completed a private placement stock offering on September 29, 2026, raising approximately $24.0 million in gross proceeds through a Stock Purchase Agreement executed on September 8, 2026. This capital raise strengthens the company's financial position during a critical period for the biopharmaceutical firm.
Key Takeaways
Company raised $24.0 million in gross proceeds through private placement of common stock
Stock Purchase Agreement was executed on September 8, 2026, with closing required by September 29, 2026
2 more takeaways
Related Filings (1)
1 more filing from Indaptus Therapeutics, Inc. in the last 90 days
Filing Overview
What This Means
Indaptus Therapeutics, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.